SEARCH

SEARCH BY CITATION

In the originally published article, the incorrect version of Figures 1 and 2 were included. These have been corrected in the online version of the paper. Also, the list of authors was incomplete. The correct author list is presented here, as well as in the corrected online version of the article.

image

Figure 1. Body weight was used to describe any potential metabolic effects of perinatal deltamethrin exposure, along with blood glucose concentration and mRNA gene expression of key factors in insulin response of WAT to describe potential effects on glucose homeostasis. Body weights of 5-month-old male mice were taken prior to sacrifice. (A) Average body weight (g) of each treatment group expressed as a mean BW ± SEM (n = 6–7). (B) Blood glucose level taken at time of necropsy of 5-month-old adult male mice expressed as a mean BG ± SEM (n = 5–6). mRNA gene expression data in WAT of 5-month-old adult male mouse pups from dams exposed to 0, 1, or 3 mg deltamethrin/kg every 3 days during getation and lactation. Total RNA was isolated from WAT, and mRNA levels were quantified by Quantigene Plex 2.0 assay. All gene expression data were normalized to Rpl13a (no significant change in gene expression) and are expressed as mean ± SEM (n = 8–9). (C) Insulin responsive and glucose transport: Irs-1, Glut-4, Glut-2 mRNA expression. mRNA gene expression data in WAT of 5-month-old adult male mouse pups from dams exposed to 0, 1, or 3 mg deltamethrin/kg every 3 days during gestation and lactation. * and # represent statistical difference between control and treatment doses (p < 0.05 and p < 0.005, respectively).

Download figure to PowerPoint

image

Figure 2. mRNA gene expression data in WAT of 5-month-old adult male mouse pups from dams exposed to 0, 1, or 3 mg deltamethrin/kg every 3 days during gestation and lactation. Total RNA was isolated from WAT, and mRNA levels were quantified by Quantigene Plex 2.0 assay. All gene expression data were normalized to Rpl13a (no significant change in gene expression) and are expressed as mean ± SEM (n = 8–9). (A) Lipogenic genes: Srebp1, Acc-1, Fabp4, Cd36, Lpl, Scd-1 mRNA expression. (B) Regulators of adipogenesis: Pparγ, Cebpα, Cebpβ mRNA expression. (C) mRNA gene expression for Nrf2, Nqo1, and Gclc was quantified by a Lightcycler 480 SYBR green qPCR method. Nrf2, Nqo1, and Gclc mRNA expression * and # represent statistical difference between control and treatment doses (p < 0.05 and p < 0.005, respectively).

Download figure to PowerPoint